Sign In
Buy AVRO
$1.40
+0 (+0%)
At Close: Sep 19, 2024
Why Is Avrobio (AVRO) Stock Moving Today?
08:26am, Thursday, 20'th Jun 2024
Avrobio (NASDAQ: AVRO ) stock is on the move Thursday as the company is preparing for two major events taking place today. The first thing to note is that Avrobio is getting ready to undergo a merge
Tectonic Therapeutic Appoints Daniel Lochner as Chief Financial Officer
04:15pm, Monday, 03'rd Jun 2024
WATERTOWN, Mass.--(BUSINESS WIRE)--Tectonic Therapeutic, Inc. (“Tectonic”), a privately-held biotechnology company developing GPCR (G-protein coupled receptor)-targeted therapeutic proteins, today
AVROBIO INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Merger of AVROBIO, Inc. - AVRO
03:40pm, Thursday, 09'th May 2024
NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed merger of AVROBIO, I
AVROBIO INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of AVROBIO, Inc. - AVRO
11:11am, Wednesday, 14'th Feb 2024
NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed merger of AVROBIO, I
Shareholder Alert: Ademi LLP investigates whether AVROBIO, Inc. has obtained a Fair Price in its transaction with Tectonic
03:08pm, Wednesday, 31'st Jan 2024
MILWAUKEE , Jan. 31, 2024 /PRNewswire/ -- Ademi LLP is investigating AVROBIO, Inc. (Nasdaq: AVRO) for possible breaches of fiduciary duty and other violations of law in its transaction with Tectonic
AVRO Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of AVROBIO, Inc. Is Fair to Shareholders
09:04am, Tuesday, 30'th Jan 2024
NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether the merger of AVROBIO, Inc. (NASDAQ: AVRO) and Tectonic Therapeutic, Inc. is fair to AVROBIO sharehol
AVROBIO and Tectonic Therapeutic Announce Merger
08:00am, Tuesday, 30'th Jan 2024
CAMBRIDGE, Mass. & WATERTOWN, Mass.--(BUSINESS WIRE)---- $AVRO--AVROBIO, Inc. (Nasdaq: AVRO) and Tectonic Therapeutic, Inc. (“Tectonic”), a privately-held biotechnology company developing GPCR (G-
Is AVROBIO (AVRO) Stock Outpacing Its Medical Peers This Year?
11:17am, Wednesday, 08'th Nov 2023
Here is how AVROBIO, Inc. (AVRO) and Crinetics Pharmaceuticals, Inc. (CRNX) have performed compared to their sector so far this year.
Is AVROBIO (AVRO) Outperforming Other Medical Stocks This Year?
11:17am, Monday, 23'rd Oct 2023
Here is how AVROBIO, Inc. (AVRO) and DaVita HealthCare (DVA) have performed compared to their sector so far this year.
Has AVROBIO (AVRO) Outpaced Other Medical Stocks This Year?
11:17am, Friday, 06'th Oct 2023
Here is how AVROBIO, Inc. (AVRO) and Brainsway Ltd. Sponsored ADR (BWAY) have performed compared to their sector so far this year.
Avrobio: Net-Net Biotech Pursuing Strategic Alternatives
04:03am, Saturday, 12'th Aug 2023
After monetizing one of its pipeline candidates, Avrobio has cash well in excess of its market cap. The company announced its search for strategic alternatives recently. The process could close its va
AVROBIO (AVRO) to Explore Strategic Options, Stock Rises 46%
08:51am, Thursday, 13'th Jul 2023
AVROBIO (AVRO) announces its decision to halt all development programs in its quest to explore strategic alternatives. The stock of the company surges 46% in response on Wednesday.
AVROBIO to Explore Strategic Alternatives
07:00am, Wednesday, 12'th Jul 2023
CAMBRIDGE, Mass.--(BUSINESS WIRE)---- $AVRO--AVROBIO, Inc. (Nasdaq: AVRO), a leading clinical-stage gene therapy company working to free people from a lifetime of genetic disease, today announced that
How to Handle Penny Stocks Volatility in 2023
06:00am, Tuesday, 23'rd May 2023
Penny stocks continue to offer incredible opportunities for investors in 2023. As high-growth, micro-cap equities, they have the potential to outperform traditional stocks, particularly given their in
Why Is AVROBIO (AVRO) Stock Up 83% Today?
11:43am, Monday, 22'nd May 2023
AVROBIO (NASDAQ: AVRO ) stock is seeing massive gains on Monday as the company sells one of its gene therapies to Novartis (NYSE: NVS ). This deal has Novartis agreeing to pay $87.5 million in cash to
